Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Best Available Treatment
Total 0 results
Nothing found
Sponsors and Collaborators
mHealth Impact Lab
London Metropolitan University
the Regional Direction of Clinical Research
Hangzhou Neoantigen Therapeutics Co., Ltd.
HMO Gesundheitsplan Basel, Switzerland
Stefano Rizza
Washington State Attorney General's Office
Universidad de Chile (UChile, Chile)
Gynea Laboratorios SA
Center for HIV/AIDS Vaccine Immunology
Nuseed Americas Inc.
Pedro Rodrigues Genta
delta medical promotions ag
WillowWood Global LLC
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
Peijas Hospital
Marealis AS
Advanced Reconstructive Surgery Alliance
IRCCS San Raffaele Roma
Hoffmann-La Roche
View Full List
Medical Conditions
Hypopigmented Skin
Orthopedics
Peroxisomal Disorders
Infantile GM2 Gangliosidosis (Disorder)
Perforation of Eardrum.
The Angle of Trunk Rotation in Thoracic Part
Deep Hypothermic Circulatory Arrest
Adult Oligoastrocytoma
Congenital Heart Disease in Children
Type D Personality
Delivery
Mindfulness-based Intervention
Urticaria Chronic
Neoplasms, Urethral
Shoulder Arthroscopy Blocks
Mitochondrial DNA Mutation
Retinal Surgery
Philadelphia Chromosome
Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms
Low-dose Corticosteroids Pretreatment
View Full List
Drug Interventions
Atorvastatin
Vincristine
Silymarin (Silybum marianum)
Rituxumab
Active Comparator: TU2670 320mg
Yohimbine hydrochloride
Simvastatin
RhGM-CSF
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Metronidazole
BIC/FTC/TAF
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Etoposide
Neridronate
Amivantamab
Immediate-release nicotinamide (SAD)
Delamanid
Basiliximab
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Ibrutinib
View Full List
CROs by country
Contract Research Organizations in Cameroon
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Estonia
Contract Research Organizations in Georgia
Contract Research Organizations in Ireland
Contract Research Organizations in Lebanon
Contract Research Organizations in Malawi
Contract Research Organizations in Oman
Contract Research Organizations in Paraguay
Contract Research Organizations in Rwanda
Contract Research Organizations in South Africa
Contract Research Organizations in Tunisia
Contract Research Organizations in Venezuela
CRO list by country
CROs in Bosnia & Herzegovina
SGS
ACROSS Global
IQVIA
PSI
BiTrial Clinical Research
SanaClis
All CROs in Bosnia & Herzegovina
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe